Literature DB >> 7694973

Control of zoonotic visceral leishmaniasis: is it time to change strategies?

R B Tesh1.   

Abstract

Zoonotic visceral leishmaniasis (ZVL) is an important emerging parasitic disease. This article reviews the recommended control methods for the disease and concludes that they have only been partially effective. The continued endemicity of ZVL, its recent appearance in urban areas of Latin America, and its increasing importance as an opportunistic infection among persons infected with human immunodeficiency virus indicate that present control methods for the disease are ineffective and that new control strategies are needed. Prevention of the disease in dogs appears to be the best approach for interrupting the domestic cycle of ZVL. The most feasible approach would seem to be a canine vaccine that protects dogs from developing parasitemia and from becoming peridomestic reservoirs of the parasite.

Entities:  

Mesh:

Year:  1995        PMID: 7694973     DOI: 10.4269/ajtmh.1995.52.287

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  58 in total

1.  The effect of removing potentially infectious dogs on the numbers of canine Leishmania infantum infections in an endemic area with high transmission rates.

Authors:  Gabriel Grimaldi; Antonio Teva; Claudiney B Santos; Adelson L Ferreira; Aloísio Falqueto
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil.

Authors:  G L Werneck; C H N Costa; A M Walker; J R David; M Wand; J H Maguire
Journal:  Epidemiol Infect       Date:  2006-07-07       Impact factor: 2.451

3.  Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.

Authors:  E Carrillo; S Ahmed; K Goldsmith-Pestana; J Nieto; Y Osorio; B Travi; J Moreno; D McMahon-Pratt
Journal:  Vaccine       Date:  2006-11-10       Impact factor: 3.641

4.  Identification of risk areas for visceral leishmaniasis in Teresina, Piaui State, Brazil.

Authors:  Andréa S de Almeida; Roberto de Andrade Medronho; Guilherme L Werneck
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

5.  Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis.

Authors:  M Soto; J M Requena; L Quijada; C Alonso
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  A serological study of Leishmania infantum in dogs of Khorasan Razavi province, Iran.

Authors:  S Sabzevari; G R Razmi; A Naghibi; J Khoshnegah
Journal:  J Parasit Dis       Date:  2012-08-22

7.  Epitope mapping of the HSP83.1 protein of Leishmania braziliensis discloses novel targets for immunodiagnosis of tegumentary and visceral clinical forms of leishmaniasis.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Matheus de Souza Gomes; João Luís Reis-Cunha; Ronaldo Alves Pinto Nagem; Cláudia Martins Carneiro; Eduardo Antônio Ferraz Coelho; Lúcia Maria da Cunha Galvão; Ricardo Toshio Fujiwara; Daniella Castanheira Bartholomeu
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

8.  Serological survey of Leishmania infantum and Trypanosoma cruzi in dogs from urban areas of Brazil and Colombia.

Authors:  A C Rosypal; J A Cortés-Vecino; S M Gennari; J P Dubey; R R Tidwell; D S Lindsay
Journal:  Vet Parasitol       Date:  2007-09-07       Impact factor: 2.738

9.  Evaluation of the influence of tissue parasite density on hematological and phenotypic cellular parameters of circulating leukocytes and splenocytes during ongoing canine visceral leishmaniasis.

Authors:  L L Guerra; A Teixeira-Carvalho; R C Giunchetti; O A Martins-Filho; A B Reis; R Corrêa-Oliveira
Journal:  Parasitol Res       Date:  2008-11-05       Impact factor: 2.289

10.  Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania.

Authors:  Blaise Dondji; Eszter Deak; Karen Goldsmith-Pestana; Eva Perez-Jimenez; Mariano Esteban; Sachiko Miyake; Takashi Yamamura; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.